Answers are grounded in this paper and cite their sources.
Background: Prostate cancer is a biologically heterogeneous disease which has become the fifth leading cause of cancer-related deaths in men worldwide. Interleukins (ILs) display required inflammation moderator. IL-2 and IL-7 play significant roles in regulating cancer-immune system interactions. So, the purpose of this investigation was to evaluate the expression level of IL-2 and IL-7 in prostate cancer patients and healthy subjects.
No takes yet. Share an insight, caveat, or question.
Namazi et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: